University Women's Hospital
Welcome,         Profile    Billing    Logout  
 16 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hartkopf, Andreas
NeoON, NCT05036005: Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label

Recruiting
4
108
Europe
Ontruzant, SB3, Chemotherapy, Pertuzumab
Institut fuer Frauengesundheit, Samsung Bioepis Co., Ltd.
Breast Cancer, Breast Neoplasms, Breast Cancer Female, HER2-positive Breast Cancer
04/23
07/23
AIRE, NCT05033769: Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer

Recruiting
4
82
Europe
Eribulin Injection [Halaven], Eribulin, Paclitaxel injection, Paclitaxel
Institut fuer Frauengesundheit, Eisai GmbH
Breast Cancer Female, Neoplasm, Breast, Breast Cancer Metastatic
07/23
09/23
ADAPTlate, NCT04565054 / 2019-001488-60: Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

Recruiting
3
1260
Europe
Abemaciclib 50 MG; 150mg 1-0-1 per os, Verzenios
West German Study Group, Eli Lilly and Company, Genomic Health®, Inc.
Breast Cancer Female
08/26
03/28
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
6000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
COMPRENDO, NCT05033756: Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (

Active, not recruiting
2
11
Europe
Pembrolizumab Injection [Keytruda], Keytruda, Olaparib Oral Tablet [Lynparza], Lynparza
Institut fuer Frauengesundheit, Merck Sharp & Dohme LLC
Malignant Neoplasm of Breast, Breast Cancer
01/25
02/26
PROOFS, NCT05792150: -Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS

Recruiting
N/A
1470
Europe
West German Study Group, Agendia
Female Breast Cancer
03/35
06/35
Krämer, Bernhard
GENERATE, NCT05867927: - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications

Recruiting
N/A
1125
Europe
Robotic-assisted surgery (da Vinci), Non-da Vinci Surgery
Intuitive Surgical
GYN Disorders
03/27
06/27
Linneweh, Miriam
No trials found
Steinhilber, Benjamin
No trials found
Böer, Bettina
No trials found

Download Options